Terumo (TSE:4543) Cyclically Adjusted Revenue per Share: 円562.04 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4543 Terumo Corp TSE:4543
92 GF Score
Price 円2,569.00
GF Value 円3,188.51
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Terumo Cyclically Adjusted Revenue per Share?

Terumo TSE:4543 -0.29% 92 Cyclically Adjusted Revenue per Share is 円562.04 as of Jun. 2026. GuruFocus rates TSE:4543 with a GF Score™ of 92/100 and a GF Value™ of 円3,188.51 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Terumo's adjusted revenue per share for the three months ended in Jun. 2026 was 円211.324. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円562.04 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Terumo's average Cyclically Adjusted Revenue Growth Rate was 10.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Terumo was 10.40% per year. The lowest was 6.20% per year. And the median was 7.30% per year.

As of today (2026-08-22), Terumo's current stock price is 円2569.00. Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was 円562.04. Terumo's Cyclically Adjusted PS Ratio of today is 4.57.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Terumo was 7.83. The lowest was 3.51. And the median was 5.34.


Terumo  (TSE:4543) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Terumo's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2569.00/562.04
=4.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Terumo was 7.83. The lowest was 3.51. And the median was 5.34.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Terumo Cyclically Adjusted Revenue per Share Related Terms


Terumo Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Terumo's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo Cyclically Adjusted Revenue per Share Chart

Terumo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 371.19 409.14 447.94 499.24 545.82

Terumo Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 510.54 521.33 536.29 545.82 562.04

TSE:4543 vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Terumo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Terumo's Cyclically Adjusted PS Ratio falls into.


TSE:4543
92GF Score
Terumo Corp TSE:4543
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Terumo Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Terumo's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=211.324/113.6000*113.6000
=211.324

Current CPI (Jun. 2026) = 113.6000.

Terumo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 77.466 98.000 89.797
201612 83.079 98.400 95.912
201703 91.798 98.100 106.302
201706 92.143 98.500 106.268
201709 96.097 98.800 110.492
201712 100.749 99.400 115.142
201803 99.624 99.200 114.086
201806 94.273 99.200 107.958
201809 93.333 99.900 106.132
201812 104.847 99.700 119.465
201903 102.969 99.700 117.325
201906 100.811 99.800 114.751
201909 102.125 100.100 115.898
201912 107.544 100.500 121.562
202003 104.903 100.300 118.813
202006 86.737 99.900 98.632
202009 100.418 99.900 114.189
202012 109.253 99.300 124.986
202103 109.169 99.900 124.140
202106 113.477 99.500 129.558
202109 114.266 100.100 129.676
202112 118.183 100.100 134.122
202203 118.800 101.100 133.488
202206 130.399 101.800 145.514
202209 136.440 103.100 150.335
202212 143.634 104.100 156.742
202303 135.730 104.400 147.691
202306 144.481 105.200 156.018
202309 153.445 106.200 164.137
202312 160.624 106.800 170.851
202403 160.839 107.200 170.441
202406 173.851 108.200 182.527
202409 168.657 108.900 175.936
202412 177.736 110.700 182.392
202503 178.222 111.100 182.232
202506 176.197 111.700 179.194
202509 186.374 112.000 189.036
202512 201.105 113.000 202.173
202603 203.551 112.700 205.177
202606 211.324 113.600 211.324

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円562.04 mean?
Terumo (TSE:4543) has a Cyclically Adjusted Revenue per Share of 円562.04 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Terumo and its competitors.
Is Terumo's Cyclically Adjusted Revenue per Share too high?
Terumo's current Cyclically Adjusted Revenue per Share is 円562.04. Overall, Terumo has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Terumo's Cyclically Adjusted Revenue per Share of 円562.04 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Terumo and its competitors. Terumo's current Cyclically Adjusted Revenue per Share is 円562.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (TSE:4543) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,188.51, compared to a current price of 円2,569.00 — trading 19.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円562.04. Terumo's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Terumo (TSE:4543), the current Cyclically Adjusted Revenue per Share is 円562.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Terumo (TSE:4543) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of 円2,569.00 is trading 19.4% below its estimated GF Value™ of 円3,188.51. GuruFocus considers Terumo to be Modestly Undervalued.

Key valuation signals for TSE:4543:

  • Cyclically Adjusted Revenue per Share: 円562.04
  • GF Value™: 円3,188.51 vs. price of 円2,569.00 (19.4% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the TSE:4543 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
92GF Score

Get the complete analysis for TSE:4543

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,569.00
Price
円3,188.51
GF Value